2578-57-6
2578-57-6
Chemical Structure
L-Prolylglycine
- CAS No.: 2578-57-6
- Formula:C7H12N2O3
- Molecular Weight:172.18
IUPAC Name: (S)-prolylglycine
InChIKey: RNKSNIBMTUYWSH-YFKPBYRVSA-N
SMILES: O=C(NCC(O)=O)[C@H]1NCCC1
Biological Activity: L-Prolylglycine is a proline-glycine dipeptide. L-Prolylglycine is absorbable through the jejunal and ileal mucosa. In streptozotocin (HY-13753)-induced diabetic mice, L-Prolylglycine reduces hepatic ALT activity and increases hepatic ALP activity. L-Prolylglycine prevents excessive elevation of blood glucose in diabetic mice. L-Prolylglycine is applicable to diabetes-related research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Prolylglycine | 99.94% | L-Prolylglycine is a proline-glycine dipeptide. L-Prolylglycine is absorbable through the jejunal and ileal mucosa. In streptozotocin (HY-13753)-induced diabetic mice, L-Prolylglycine reduces hepatic ALT activity and increases hepatic ALP activity. L-Prolylglycine prevents excessive elevation of blood glucose in diabetic mice. L-Prolylglycine is applicable to diabetes-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Prolylglycine (Standard) | ≥98% | L-Prolylglycine (Standard) is the analytical standard of L-Prolylglycine (HY-WAA0142). This product is intended for research and analytical applications. L-Prolylglycine is a proline-glycine dipeptide. L-Prolylglycine is absorbable through the jejunal and ileal mucosa. In streptozotocin (HY-13753)-induced diabetic mice, L-Prolylglycine reduces hepatic ALT activity and increases hepatic ALP activity. L-Prolylglycine prevents excessive elevation of blood glucose in diabetic mice. L-Prolylglycine is applicable to diabetes-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lane AE, et al. Absorption of two proline containing peptides by rat small intestine in vivo. The Journal of physiology. 1975 Jun;248(1):143-9. [Content Brief]
- [2]. Mesgari-Abbasi M, et al. Protective effects of di- and tri-peptides containing proline, glycine, and leucine on liver enzymology and histopathology of diabetic mice. Archives of physiology and biochemistry. 2022 Feb;128(1):59-68. [Content Brief]
